Search Results for: hepatitis c

September 25, 2014September 25, 2014

Gilead Files Fixed-Dose Hepatitis C Combo NDA for Japanese Market

Hepatitis C, News

Gilead Sciences, Inc. recently submitted a New Drug Application (NDA) to the Pharmaceutical and Medical Devices Agency (PMDA) in Japan for approval of an experimental combination therapy of the NS5A inhibitor ledipasvir ... Read more

September 24, 2014September 24, 2014

Scientists Board Space Station to Crystallize Hepatitis C Proteins

News

The World Health Organization has declared Hepatitis C a global health concern, and Egypt is at its epicenter, with nearly 8% of its population diagnosed with a chronic hepatitis C ... Read more

September 23, 2014September 23, 2014

Janssen Heralds NICE Ruling on Hepatitis C Drug Olysio For Patients With Genotype 1, Calls For Further Approval For Genotype 4

Hepatitis C, News

The National Institute of Health and Care Excellence (NICE) recently released the Appraisal Consultation Document (ACD) for the use of Olysio® (simeprevir), developed jointly by Janssen R&D Ireland and Medivir ... Read more

June 1, 2017June 1, 2017

Survey Reports Gaps in Hepatitis Testing and Monitoring Across European Union

Hepatitis B, Hepatitis C, News

Results from a European Centre for Disease Prevention and Control (ECDC) survey suggest that European Union/European Economic Area (EU/EEA) member states suffer from significant gaps in national testing policies and ... Read more

May 25, 2017May 25, 2017

FDA Reviewing Application for Opdivo Use in Hepatocellular Carcinoma, Often Caused by Hepatitis

Hepatitis B, Hepatitis C, News

The U.S. Food and Drug Administration (FDA) recently accepted a supplemental Biologics License Application (sBLA) to extend the use of Opdivo (nivolumab) to patients with hepatocellular carcinoma (HCC). People chronically infected with hepatitis ... Read more

May 24, 2017May 24, 2017

Graphene Sensor Device Under Development to Provide Low-Cost Diagnosis of Multiple Hepatitis Types

News

Researchers in the U.K. and China are collaborating on the development of a low-cost, noninvasive electronic sensor device to simultaneously test for three types of hepatitis. The technology uses graphene, ... Read more

May 9, 2017May 9, 2017

Newly Diagnosed Cases of Hepatitis Delta Virus Infection in US is Increasing

Hepatitis B, Hepatitis D, News

The number of people newly diagnosed with Hepatitis Delta virus (HDV) infection in the United States is increasing. Furthermore, the incidence of HDV co-infection among chronic Hepatitis B virus (HBV) patients ... Read more

May 4, 2017May 4, 2017

Eiger Files New Drug Application for Lambda as Hepatitis D Therapy, Starts Clinical Trials

Hepatitis B, Hepatitis D, News

Eiger BioPharmaceuticals has filed an investigational new drug (IND) application with the U.S. Food and Drug Administration (FDA) for Lambda (pegylated interferon lambda 1a) as a treatment for the hepatitis ... Read more

April 18, 2017April 18, 2017

RTT MolecularDX Launches Tests to Detect Drug-resistant Hepatitis Viruses

Hepatitis B, Hepatitis C, News

RTT MolecularDx recently announced the pre-market launch of new genotyping tests to detect the presence of hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus type 1 (HIV-1), and ... Read more

April 6, 2017April 6, 2017

ContraVir Reports New Mechanism of Action for Hepatitis B Virus Inhibitor CRV431

Hepatitis B, News

ContraVir Pharmaceuticals, a New Jersey-based biopharma company that develops and commercializes antiviral therapies, is providing new insights into the mechanism of action of its hepatitis B virus (HBV)-optimized cyclophilin inhibitor CRV431. ... Read more